Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hisamitsu Pharmaceutical Co Inc

+ Add to Watchlist

4530:JP

5,140.0 JPY 40.0 0.77%

As of 02:00:00 ET on 05/22/2015.

Snapshot for Hisamitsu Pharmaceutical Co Inc (4530)

Open: 5,230.0 Day's Range: 5,120.0 - 5,230.0 Volume: 95,000
Previous Close: 5,180.0 52wk Range: 3,335.0 - 5,360.0 1-Yr Rtn: +27.44%

Stock Chart for 4530

No chart data available.
  • 4530:JP 5,130.0
  • 1D
  • 1M
  • 1Y
5,180.0
Interactive 4530 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4530

Current P/E Ratio (ttm) 23.4414
Estimated P/E(02/2016) 23.3251
Relative P/E vs. TPX 1.2545
Earnings Per Share (JPY) (ttm) 219.2700
Est. EPS (JPY) (02/2016) 220.3630
Est. PEG Ratio -
Market Cap (M JPY) 489,147.56
Shares Outstanding (M) 95.16
30 Day Average Volume 185,897
Price/Book (mrq) 1.9922
Price/Sale (ttm) 2.8093
Dividend Indicated Gross Yield 1.56%
Cash Dividend (JPY) 40.0000
Dividend Ex-Date 08/27/2015
5 Year Dividend Growth 3.30%
Next Earnings Announcement 07/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4530

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4530

HISAMITSU PHARMACEUTICAL CO., INC. produces and sells pharmaceutical products. The Company's main product is anti-inflammatory analgesic plasters and poultices sold under the brand name Salonpas. Hisamitsu Pharmaceutical exports its products to North America and Southeast Asia. The Company also researches and develops antibacterial products through its related company, RRF.

Hirotaka NakatomiChairman/CEOKazuhide NakatomiPresident/COO
Kosuke SugiyamaSenior Managing DirectorTetsuo AkiyamaManaging Director
More Company Profile & Key Executives for 4530

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil